Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A van Es

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Circulation|September 1, 1995
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study GroupT Lenderink, M L Simoons, G A Van Es, et al.
European Heart Journal|December 1, 1987
ST 567 (alinidine) in stable angina: a comparison with metoprololK Balakumaran, A Jovanovic, P W Fels, et al.
Epidemiology (Cambridge, Mass.)|May 7, 1999
Redundancy of single diagnostic test evaluationK G Moons, G A van Es, B C Michel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curvesK G Moons, T Stijnen, B C Michel, et al.
European Journal of Pharmacology|December 6, 1997
Effect of acadesine on myocardial ischaemia in patients with coronary artery diseaseR de Jonge, D C Macleod, H Suryapranata, et al.
Journal of the American College of Cardiology|September 1, 1989
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PAA E Arnold, R W Brower, D Collen, et al.
Circulation|November 7, 2001
Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary interventionP N Ruygrok, M W Webster, V de Valk, et al.
Journal of Clinical Epidemiology|July 1, 1997
Efficiency optimization of the selection period in therapeutic trialsC K Moons, G A van Es, T Stijnen, et al.
Journal of the American College of Cardiology|August 31, 2001
Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent eraN Mercado, E Boersma, W Wijns, et al.
Statistics in Medicine|October 30, 2019
Generalized pairwise comparison methods to analyze (non)prioritized composite endpointsJ Verbeeck, E Spitzer, T de Vries, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Circulation|September 1, 1995
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study GroupT Lenderink, M L Simoons, G A Van Es, et al.
European Heart Journal|December 1, 1987
ST 567 (alinidine) in stable angina: a comparison with metoprololK Balakumaran, A Jovanovic, P W Fels, et al.
Epidemiology (Cambridge, Mass.)|May 7, 1999
Redundancy of single diagnostic test evaluationK G Moons, G A van Es, B C Michel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curvesK G Moons, T Stijnen, B C Michel, et al.
European Journal of Pharmacology|December 6, 1997
Effect of acadesine on myocardial ischaemia in patients with coronary artery diseaseR de Jonge, D C Macleod, H Suryapranata, et al.
Journal of the American College of Cardiology|September 1, 1989
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PAA E Arnold, R W Brower, D Collen, et al.
Circulation|November 7, 2001
Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary interventionP N Ruygrok, M W Webster, V de Valk, et al.
Journal of Clinical Epidemiology|July 1, 1997
Efficiency optimization of the selection period in therapeutic trialsC K Moons, G A van Es, T Stijnen, et al.
Journal of the American College of Cardiology|August 31, 2001
Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent eraN Mercado, E Boersma, W Wijns, et al.
Statistics in Medicine|October 30, 2019
Generalized pairwise comparison methods to analyze (non)prioritized composite endpointsJ Verbeeck, E Spitzer, T de Vries, et al.
Pageof 4